DRUG REPURPOSING FOR ATHEROSCLEROSIS TREATMENT

DRUG REPURPOSING FOR ATHEROSCLEROSIS TREATMENT

DRUG REPURPOSING FOR ATHEROSCLEROSIS TREATMENT

New medical use of P15/P16 agonists for the treatment of atherosclerosis. These drugs would act as stabilizers of atheroma plaque through a new mechanism of action based on immune system modulation.

INDUSTRIAL PROPERTY RIGHTS

A European patent application has been filed related
to this technology.

Industry environment: Health Promotion and Efficient Health
Entity: Fundación para la Investigación del Hospital Cl´nico de la COmunitat Valenciana (INCLIVA)

CONTACT:

INCLIVA Innovation Unit
uai@incliva.es